Loading insider details...
Latest Form 4 (May 12, 2026): Grant/Award of 22,000 INAB shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 12, 2026 | IN8BIO, INC. (INAB) | Grant/Award | 22,000 | n/a |
| May 12, 2025 | IN8BIO, INC. (INAB) | Grant/Award | 63,150 | n/a |
| Dec 23, 2024 | IN8BIO, INC. (INAB) | Grant/Award | 39,449 | n/a |
| Sep 17, 2024 | Traws Pharma, Inc. (TRAW) | Grant/Award | 164,000 | n/a |
| Jun 14, 2024 | IN8BIO, INC. (INAB) | Grant/Award | 33,650 | n/a |
| Jun 16, 2023 | IN8BIO, INC. (INAB) | Grant/Award | 85,000 | n/a |
| Aug 18, 2022 | IN8BIO, INC. (INAB) | Purchase | 526 | $999.40 |
| Jun 14, 2022 | IN8BIO, INC. (INAB) | Grant/Award | 10,500 | n/a |
| Dec 10, 2021 | Brooklyn ImmunoTherapeutics, Inc. (BTX) | Grant/Award | 67,000 | n/a |
| Aug 3, 2021 | IN8BIO, INC. (INAB) | Grant/Award | 21,000 | n/a |